Digital Education in Colorectal Cancer Patients

NCT07686133 | Enrolling By Invitation

• 1 other identifier: 24-5230
• Study Type: interventional
• Target: 100
• Locations: 1 country
• Sites: 1

Brief Summary

The goal of this clinical trial is to evaluate the impact of integrating video- based education in colorectal cancer surgery, with a specific focus on patient's perspective. The main questions it aims to answer are: Does addition of video-based patient education material lower patient's anxiety around colorectal cancer surgery? Does it increase patient's understanding of their diagnosis? Does it enhance patient's sense of shared decision-making? Researchers will compare an addition of video-based education to a standard surgical consultation to see if video improves patient's experience with colorectal cancer surgery. Participants will be randomized at the time of referral. Intervention group will view the video prior to the surgical consultation. They will complete the survey at the end of the surgical consultation.

Conditions

Colorectal Cancer; Patient Engagement; Patient; Patient Satisfaction

Keywords

Video-based education

Outcome Measures

Primary Outcomes (4)

• Anxiety related to colorectal cancer surgery

  Assessed using the Questionnaire on Stress in Cancer Patients-Revised (QSC-R10), a 10-item, 5-point Likert scale. Scores range from 0 to 50, with higher scores indicating greater cancer-related distress.

  Baseline

• Disease-related information received

  Assessed using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Information Module (EORTC QLQ-INFO25). Scores are transformed to a 0-100 scale, with higher scores indicating better perceived information received.

  Baseline

• Physician-patient relationship

  Assessed using the Patient-Doctor Relationship Questionnaire (PDRQ-9), a 9-item, 5-point Likert scale. Scores range from 9 to 45, with higher scores indicating a better physician-patient relationship.

  Baseline

• Shared decision-making

  Assessed using the 9-item Shared Decision-Making Questionnaire (SDM-Q-9). Scores range from 0 to 45, with higher scores indicating greater shared decision-making.

  Baseline

Study Arms (2)

Intervention

OTHER

Obtaining access to the video platform and surgical consultation

Other: Video platform

Control

NO INTERVENTION

Surgical consultation only, with an option to gain access to videos upon completion of the outcome survey

Interventions

Video platform OTHER

Participants in the intervention arm will obtain access to the video platform and have the surgical consultation.

Intervention

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Adult patients (≥18 years of age).
• Biopsy-proven adenocarcinoma of the colon or rectum.
• Evaluated for surgical resection at the University Health Network (UHN).
• Undergoing elective, curative-intent: Right hemicolectomy, Left hemicolectomy, Sigmoid resection, Low anterior resection, Abdominoperineal resection

You may not qualify if:

• Age \<18 years.
• Emergency surgery.
• Palliative surgery.

Sponsors & Collaborators

• University Health Network, Toronto: lead
• AFP Innovation Fund: collaborator

Study Sites (1)

Toronto General Hospital

Toronto, Canada

Location

MeSH Terms

Conditions

Colorectal Neoplasms; Patient Satisfaction; Patient Participation

Condition Hierarchy (Ancestors)

Intestinal Neoplasms; Gastrointestinal Neoplasms; Digestive System Neoplasms; Neoplasms by Site; Neoplasms; Digestive System Diseases; Gastrointestinal Diseases; Colonic Diseases; Intestinal Diseases; Rectal Diseases; Treatment Adherence and Compliance; Health Behavior; Behavior; Patient Acceptance of Health Care

Study Officials

• Karineh Kazazian, MD PhD

  University Health Network, Toronto

  PRINCIPAL INVESTIGATOR

• Sami A Chadi, MD MSc

  University Health Network, Toronto

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: June 24, 2026
• First Posted: July 7, 2026
• Study Start: March 10, 2026
• Primary Completion (Estimated): January 1, 2027
• Study Completion (Estimated): October 1, 2027
• Last Updated: July 7, 2026

Record last verified: 2026-07

Locations

CA (1)